ReviewInternational journal of nanomedicine2026
Microfluidic Fabrication of Functional Micro-/Nanoparticles: From Structural Regulation to Scalable Integration.
Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Functional particles play critical roles in biomedicine, sensing, catalysis, energy storage and conversion, and environmental remediation. Conventional bulk synthesis can provide limited control over local reaction environments when narrow size distributions, complex morphologies, or hierarchical architectures are required. Microfluidic synthesis addresses these limitations by confining reactions within microscale channels, droplets, or flow segments, thereby enabling controlled multiphase flow, rapid heat and mass transfer, and precise regulation of local reaction conditions. This review is organized around a particle formation/process control/particle properties/scale-up framework, linking microfluidic design and operating parameters to nucleation, growth, phase separation, interfacial assembly, and solidification, and subsequently to particle size, morphology, dispersity, and hierarchical structure. Representative strategies, including droplet microfluidics, hydrodynamic focusing, co-flow systems, structured microchannels, and integrated microreactors, are critically compared in terms of particle-quality control and manufacturing feasibility. Particular attention is given to scalability, productivity, process robustness, clogging, downstream processing, and internal and external integration. Although microfluidic processing can improve control and reproducibility, many reported systems remain at the proof-of-concept or laboratory scale. Future development therefore requires quantitative process-structured relationships, robust device engineering, in-line monitoring, feedback control, and validated scale-up strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.